ONCY

#3929
Oncolytics Biotech, Inc. Common Shares
1.05 USD
+2.94%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
1.02
1.07
Yıllık Aralık
0.33
1.51
Günlük Değişim
+2.94%
Aylık Değişim
+6.06%
6 aylık değişim
-13.93%
Yıllık Değişim
+81.03%
Önceki Kapanış
1.02
Open
1.03
Bid
Ask
Low
1.02
High
1.07
Hacim
107
Open full chart

Financials

Overview Rapor Statistics
Quarterly Annual
  • Market Capitalization 121.93 M
  • Employee 29
  • Founded 1998
  • CEO N/A
  • Website www.oncolyticsbiotech.com
  • Headquarter Nevada, United States
  • FIGI BBG000DVS826
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.91
Price to sales ratio
-169.59

Oncolytics Biotech Inc

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Haberler